Browse

THE EFFECTS OF A HEAD AND NECK MULTIDISCIPLINARY CLINIC ON PATIENT SATISFACTION

Education / Care Delivery

Ricardo Aulet, Md, MBA¹; Christine Chung, MD²; Louis Harrison, MD, FASTRO²; Trad Wadsworth, MD, MBA²

¹UMass Memorial Medical Center; ²Moffitt Cancer Center

TRENDS IN THE PRESENCE OF WOMEN SPEAKERS AT THE AMERICAN HEAD & NECK SOCIETY MEETINGS FROM 2007-2019

Education / Care Delivery

Alice L Tang, MD

University of Cincinnati College of Medicine

TIME-TO-TREATMENT IN HEAD AND NECK CANCER IS ASSOCIATED WITH INCOME, RACE, AND SEX

Education / Care Delivery

Wesley Stepp; Siddharth Sheth, MD, MPH; Jeffery Blumberg, MD; Catherine Lumley, MD; Samip Patel, MD; Trevor Hackman, MD; Adam Zanation; Andrew Olshan, PhD

University of North Carolina

COST-EFFECTIVENESS OF CIRCULATING TUMOR HPV DNA FOR THE SURVEILLANCE OF CANCER RECURRENCE IN HPV-ASSOCIATED OROPHARYNGEAL CANCER

Oropharynx / HPV Related Disease

Matthew C Ward, MD¹; Gary V Walker²; Benjamin Moeller, MD, PhD¹; Shlomo A Koyfman³; Chirag Shah³

¹Levine Cancer Institute, Atrium Health; ²Banner MD Anderson; ³Taussig Cancer Institute, Cleveland Clinic

VALIDATION OF NRG ONCOLOGY’S PROGNOSTIC NOMOGRAMS FOR OROPHARYNGEAL CANCER IN THE VETERANS AFFAIRS DATABASE

Oropharynx / HPV Related Disease

Tyler J Nelson, BS¹; Abhishek Kumar, MD¹; Jingjing Zou, PhD²; Caroline A Thompson, PhD³; Casey Williamson, MD¹; Prangrawee Sangchan, MD⁴; Lucas Vitzthum, MD⁵; Andrew Sharabi, MD¹; James Murphy, MD, MPH¹; Carole Fakhry, MD⁶; Loren K Mell, MD¹

¹Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; ²Department of Family Medicine and Public Health and Department of Mathematics, University of California San Diego, La Jolla, California; ³Division of Epidemiology, San Diego State University School of Public Health, San Diego, California; ⁴Division of Radiation Oncology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand; ⁵Department of Radiation Oncology, Stanford University; ⁶Department of Otolaryngology, Johns Hopkins University

ADJUVANT RADIATION VS CHEMORADIATION IN HPV+ OROPHARYNGEAL SQUAMOUS CELL CARCINOMA WITH EXTRANODAL EXTENSION

Oropharynx / HPV Related Disease

Samer T Elsamna, BA; Ghayoour Mir, DO; Dylan F Roden, MD, MPH

Rutgers New Jersey Medical School, Department of Otolaryngology—Head & Neck Surgery

ORAL CAVITY SQUAMOUS CELL CARCINOMA TUMOR CENTER AND LEADING EDGE HAVE A TEMPORALLY STABLE, UNIQUE MICROBIOME COMPARED TO CONTRALATERAL NORMAL SITES

Oral Cavity

Carissa M Thomas, MD, PhD¹; Alya Heirali, PhD²; Hedyeh Ziai, MD³; Maria Kulikova, BS, DPT²; Carolyn Barsoum, BS, MA³; Feben Alemu³; Dale Brown, MB³; John R de Almeida, MD, MSc³; David Goldstein, MD, MSc³; Patrick Gullane, MB³; Ralph Gilbert, MD³; Jonathan Irish, MD, MSc³; Douglas Chepeha, MD, MSCPH³; Bryan Coburn, MD, PhD²

¹University of Alabama at Birmingham; ²Toronto General Research Institute; ³University Health Network, University of Toronto

IDENTIFICATION OF OCCULT METASTATIC DISEASE VIA LYMPHOSCINTIGRAPHY GUIDED NECK DISSECTION (LSG-ND) IN N0 ORAL SQUAMOUS CELL CARCINOMA

Oral Cavity

Lisa B Earnest-Noble, MD, PhD; Rachel Lipsky; William I Kuhel, MD; David I Kutler, MD

Weill Cornell Medicine

PROTEIN BIOMARKERS AS INDEPENDENT PREDICTORS OF PROGNOSIS AND CLINICOPATHOLOGIC OUTCOMES IN ORAL CAVITY SQUAMOUS CELL CARCINOMA

Oral Cavity

Daniel J Lee, MD; Nitin Pagedar, MD; Anand Rajan, MBBS, MD; Marisa Buchakjian, MD, PhD; Steven Sperry, MD

University of Iowa

THE SUBSTANTIAL OMISSION OF INDICATED POST-OPERATIVE RADIOTHERAPY IN ADVANCED STAGE ORAL CANCER IN THE UNITED STATES: A CALL TO ACTION

Oral Cavity

1; Ken Akakpo, MD¹; Becky Massey, MD¹; Michael Stadler, MD¹; Bruce Campbell, MD¹; Monica Shukla, MD¹; Christopher Schultz, MD¹; Aditya Shreenivas, MD¹; Stuart Wong, MD¹; Evan Graboyes, MD, MPH²; Patrik Pipkorn, MD, MSCI³; Sidharth V Puram, MD, PhD³; Joseph Zenga¹

¹Medical College of Wisconsin; ²Medical University Of South Carolina; ³Washington University School of Medicine